Melbourne, Feb 6, 2009 AEST (ABN Newswire) - Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) today announced that it had received written notification from GlaxoSmithKline (GSK) that Relenza sales were A$20.8 million and indicative royalties were A$1.46 million, for the three months ended 31 December 2008.
Contact
Investor / Analyst Enquiries
Biota Holdings Limited
Peter Cook,
T: +61 3 9915 3720
Damian Lismore,
T: +61 3 9915 3721
| ||
|
